Literature DB >> 23955616

Platypnea-orthodeoxia syndrome caused by a latent atrial septal defect.

Hiroto Takiguchi1, Kyoko Niimi, Takuya Aoki, Rin Ogiya, Yohei Ohno, Gaku Nakazawa, Yuji Ikari, Tadashi Abe, Koichiro Asano.   

Abstract

A 79-year-old woman presented with unexplained hypoxia that became exacerbated by an upright posture (platypnea-orthodeoxia syndrome). A (99m)Tc-macroaggregated albumin pulmonary perfusion scan revealed a right to left shunt of 25.5% in the supine position and 32.3% in the sitting position. A dynamic CT scan and a transoesophageal echocardiogram confirmed the presence of a shunt across an atrial septal defect (ASD). A percutaneous transcatheter closure of the defect significantly improved the patient's blood oxygenation levels when she was in the upright position. An ASD should therefore be included in the differential diagnosis of platypnea-orthodeoxia syndrome, regardless of the patient's age.

Entities:  

Mesh:

Year:  2012        PMID: 23955616     DOI: 10.2169/internalmedicine.52.0578

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Multi-modal and multi-postural assessment of platypnea-orthodeoxia syndrome triggered by stroke: A case report.

Authors:  Keisuke Matsuo; Shintaro Nakano; Masanori Katayama; Saki Hasegawa; Kenji Fukushima
Journal:  J Cardiol Cases       Date:  2021-09-15

2.  Posture-Related Change in Intracardiac Blood Flow Detected by Transesophageal Echocardiography in Platypnea-Orthodeoxia Syndrome.

Authors:  Hibiki Mima; Jiro Sakamoto; Makoto Miyake; Yodo Tamaki; Soichiro Enomoto; Hirokazu Kondo; Toshihiro Tamura
Journal:  CASE (Phila)       Date:  2022-04-30

3.  Platypnea-orthodeoxia Syndrome in a Patient with an Atrial Septal Defect: The Diagnosis and Choice of Treatment.

Authors:  Shuichiro Kazawa; Takashi Enomoto; Naomasa Suzuki; Tomoyasu Koshikawa; Yuka Okubo; Shinpei Yoshii; Masahito Sato; Masaaki Okabe; Akira Yamashina; Yoshifusa Aizawa
Journal:  Intern Med       Date:  2017-01-15       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.